Skip to Main Content
Services Talent Knowledge
Site Search
Menu

PressRelease

May 29, 2025

Barclay Damon Attorneys Selected to 2025 Washington DC Super Lawyers List

Barclay Damon announces Michael Dorfman, partner; Laura Fraher, Power & Energy Construction Practice Area co-chair; Judah Lifschitz, co-chair of the Construction & Surety and Power & Energy Construction Practice Areas; and Steve Schram, partner, have been selected to the 2025 Washington DC Super Lawyers list. Dorfman was recognized in the Intellectual Property Litigation category, Fraher and Lifschitz were recognized in the Construction Litigation category, and Schram was recognized in the Business / Corporate category. Dorfman, Fraher, Lifschitz, and Schram practice out of the firm’s Washington DC office.

Each year, no more than 5 percent of the lawyers in the state are selected by the research team at Super Lawyers to receive this honor.

Barclay Damon attorneys team across offices and practices to provide customized, targeted solutions grounded in industry knowledge and a deep understanding of our clients' businesses. With approximately 300 attorneys, Barclay Damon is a leading regional law firm that operates from a strategic platform of offices in Albany, Boston, Buffalo, New Haven, New York City, Rochester, Syracuse, Washington DC, and Toronto. Our firm serves clients across the country and, for some practices, provides US legal services around the globe. For more information, visit our award-winning website at barclaydamon.com.
 

Featured Media

Alerts

Legacy Article VII Transmission Certificates Move Into the Article VIII Framework

Alerts

Final CTA Rule Permanently Ends Domestic Reporting Requirements

Alerts

CLCPA Overhaul Met With Enforcement Letters, Not Regulatory Action

Alerts

Could Your Website Be an "App Store" Under Texas's App Store Accountability Act?

Alerts

Update: NYS DOH Clarifies Medicaid Enrollment Moratorium and Provider Revalidation Requirements

Alerts

New York State Announces Six-Month Moratorium on Medicaid Enrollment for Certain "High-Risk" Provider Types